Burton Eisenberg

Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

George D. Demetri, Margaret von Mehren, Charles D. Blanke et al. · New England Journal of Medicine · 2002 · 4.4K citations · Full text

Medicine, Oncology, Pharmacology +14

Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

Michael C. Heinrich, Christopher L. Corless, George D. Demetri et al. · Journal of Clinical Oncology · 2003 · 2.3K citations

Medicine, Molecular Medicine, Oncology +17

Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing <i>KIT</i>

Charles D. Blanke, George D. Demetri, Margaret von Mehren et al. · Journal of Clinical Oncology · 2008 · 1K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Molecular Correlates of Imatinib Resistance in Gastrointestinal Stromal Tumors

Michael C. Heinrich, Christopher L. Corless, Charles D. Blanke et al. · Journal of Clinical Oncology · 2006 · 814 citations

Medicine, Molecular Medicine, Oncology +17

Soft tissue sarcomas of adults: state of the translational science.

Ernest C. Borden, Laurence H. Baker, Robert S. Bell et al. · PubMed · 2003 · 616 citations

Medicine, Molecular Biology, Oncology +17